We did not find differences in the composition ratio of CD4+ T cells, CD8+ T cells, CD20+ B cells, CD45RO+ lymphocyte, CD11c+ DCs, CD68+ TAMs and CD15+ TANs between P-TLS and In-TLS. This evidence concerns the gene CD8A and Tumor Lysis Syndrome.